May 23, 2019
The Ministry of Health, Labor and Welfare (MHLW) on May 22 approved new indications and dosages for six drugs including Takeda Pharmaceutical’s inflammatory bowel disease medicine Entyvio (vedolizumab) for the treatment of Crohn’s disease (CD). Entyvio earned approval for use...read more